< 生产厂家价格 >

4-(溴乙烷)苯乙酸

4-(溴乙烷)苯乙酸名称

[ CAS 号 ]:
13737-36-5

[ 中文名 ]:
4-(溴甲基)苯乙酸

[ 英文名 ]:
4-(bromomethyl)phenyl acetic acid

[中文别名 ]:

[英文别名 ]:

4-(Carboxymethyl)benzyl Bromide
2-[4-(bromomethyl)phenyl]acetic acid
MFCD00010632
4-(BROMOMETHYL)PHENYLACETIC ACID
Benzeneacetic acid, 4-(bromomethyl)-
[4-(Bromomethyl)phenyl]acetic acid
4-(bromomethyl)phenyl acetic acid

4-(溴乙烷)苯乙酸物理化学性质

[ 密度 ]:
1.6±0.1 g/cm3

[ 沸点 ]:
343.1±22.0 °C at 760 mmHg

[ 熔点 ]:
179-183 °C(lit.)

[ 分子式 ]:
C₉H₉BrO₂

[ 分子量 ]:
229.071

[ 闪点 ]:
161.3±22.3 °C

[ 精确质量 ]:
227.978592

[ PSA ]:
37.30000

[ LogP ]:
2.21

[ 蒸汽压 ]:
0.0±0.8 mmHg at 25°C

[ 折射率 ]:
1.599

[ 储存条件 ]:
Store at RT.

4-(溴乙烷)苯乙酸MSDS

4-(溴乙烷)苯乙酸安全信息

[ 符号 ]:

GHS07, GHS08

[ 信号词 ]:
Danger

[ 危害声明 ]:
H315-H319-H334-H335

[ 警示性声明 ]:
P261-P305 + P351 + P338-P342 + P311

[ 个人防护装备 ]:
dust mask type N95 (US);Eyeshields;Faceshields;Gloves

[ 危害码 (欧洲) ]:
Xi:Irritant

[ 风险声明 (欧洲) ]:
R36/37/38;R42

[ 安全声明 (欧洲) ]:
S26-S36

[ 危险品运输编码 ]:
UN3261

[ WGK德国 ]:
3

[ 包装等级 ]:
III

[ 危险类别 ]:
8

[ 海关编码 ]:
2916399090

4-(溴乙烷)苯乙酸合成路线

4-(溴乙烷)苯乙酸上下游产品

4-(溴乙烷)苯乙酸上游产品

4-(溴乙烷)苯乙酸下游产品

4-(溴乙烷)苯乙酸海关

[ 海关编码 ]: 2916399090

[ 中文概述 ]:
2916399090 其他芳香一元羧酸. 增值税率:17.0% 退税率:9.0% 监管条件:无最惠国关税:6.5% 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 丙烯酸、丙烯酸盐或酯应报明包装

[ Summary ]:
2916399090 other aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%

4-(溴乙烷)苯乙酸文献

J. Chem. Soc. Chem. Commun. , 399, (1993)

Effect of conformational mobility and hydrogen-bonding interactions on the selectivity of some guanidinoaryl-substituted mechanism-based inhibitors of trypsin-like serine proteases.

J. Med. Chem. 35 , 4297, (1992)

Previously, we have reported that some guanidino-substituted alpha- and beta-aryl enol lactones I and II behaved as selective, mechanism-based inhibitors of some trypsin-like proteases (Rai, R.; Katze...

Synthesis and anti-inflammatory activity of the major metabolites of imrecoxib.

Bioorg. Med. Chem. Lett. 19(8) , 2270-2, (2009)

We have developed a novel and moderately selective COX-2 inhibitor, imrecoxib, as a new anti-inflammatory drug. We describe herein the preparation of the major metabolites M2 and M4 of imrecoxib, as w...

更多文献